Aspirin as adjuvant therapy for colorectal cancer--reinterpreting paradigms.
about
Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and diseaseAnti-angiogenesis or pro-angiogenesis for cancer treatment: focus on drug distributionEMAST is a Form of Microsatellite Instability That is Initiated by Inflammation and Modulates Colorectal Cancer ProgressionDiscovery of colorectal cancer PIK3CA mutation as potential predictive biomarker: power and promise of molecular pathological epidemiologyChemopreventive drugs: mechanisms via inhibition of cancer stem cells in colorectal cancerClinical advances in molecular biomarkers for cancer diagnosis and therapyDissecting the Dual Role of AMPK in Cancer: From Experimental to Human StudiesChemoprevention of metastasisProceedings of the third international molecular pathological epidemiology (MPE) meeting.Molecular pathological epidemiology: new developing frontiers of big data science to study etiologies and pathogenesis.Aspirin and the risk of colorectal cancer in relation to the expression of 15-hydroxyprostaglandin dehydrogenase (HPGD)New frontiers in the treatment of colorectal cancer: Autophagy and the unfolded protein response as promising targetsImmune cells: plastic players along colorectal cancer progressionProgress and opportunities in molecular pathological epidemiology of colorectal premalignant lesions.Cost-effectiveness of aspirin adjuvant therapy in early stage colorectal cancer in older patients.Roles of tumor suppressors in regulating tumor-associated inflammation.Proceedings of the second international molecular pathological epidemiology (MPE) meetingGenetic variation in UGT genes modify the associations of NSAIDs with risk of colorectal cancer: colon cancer family registry.Lack of significant association between serum inflammatory cytokine profiles and the presence of colorectal adenomaInflammaging and cancer: a challenge for the Mediterranean dietMultiple Mechanisms of Anti-Cancer Effects Exerted by Astaxanthin.The Influence of BRAF and KRAS Mutation Status on the Association between Aspirin Use and Survival after Colon Cancer Diagnosis.Integration of molecular pathology, epidemiology and social science for global precision medicine.Survival Benefit of Exercise Differs by Tumor IRS1 Expression Status in Colorectal Cancer.Prospective analysis of body mass index, physical activity, and colorectal cancer risk associated with β-catenin (CTNNB1) status.Physical activity, tumor PTGS2 expression, and survival in patients with colorectal cancerReview Article: The Role of Molecular Pathological Epidemiology in the Study of Neoplastic and Non-neoplastic Diseases in the Era of Precision Medicine.A prospective study of duration of smoking cessation and colorectal cancer risk by epigenetics-related tumor classificationMicrosatellite instability and BRAF mutation testing in colorectal cancer prognosticationAspirin use and risk of colorectal cancer according to BRAF mutation statusThe Immune Landscapes of Polypoid and Nonpolypoid Precancerous Colorectal LesionsPredictive and prognostic analysis of PIK3CA mutation in stage III colon cancer intergroup trial.Tumor LINE-1 methylation level and colorectal cancer location in relation to patient survival.Targeting mTOR network in colorectal cancer therapyThe discovery and development of cyclooxygenase-2 inhibitors as potential anticancer therapies.Biotransformation of xenobiotics in the human colon and rectum and its association with colorectal cancer.Nonsteroidal anti-inflammatory drugs suppress cancer stem cells via inhibiting PTGS2 (cyclooxygenase 2) and NOTCH/HES1 and activating PPARG in colorectal cancer.The immune response in cancer: from immunology to pathology to immunotherapy.The colorectal cancer immune microenvironment and approach to immunotherapies.Examining the impact of regular aspirin use and PIK3CA mutations on survival in stage 2 colon cancer.
P2860
Q24289344-C98AD816-AB38-4319-B1B6-F27B77ABF2B4Q26796955-916B56D5-0031-47FF-A45D-09BF45C206F8Q26995653-E976747D-B471-472C-B203-F57F15D0FDCAQ27011884-35A1B2E8-8D27-4D6D-8B56-3770E379840AQ27026428-08EEBC2A-DDED-4F73-A39A-6D38FCE58D80Q27027560-141F31CC-B21A-4161-AC3D-3D0954EF256CQ28081491-0ACDDE35-C211-4470-85D2-1116B6B1E7BCQ28395816-C9B1D9D8-09AC-4087-AF10-90FEE0A7336EQ30238962-016D34C7-ECC9-4C54-B934-A7BB955AD974Q30244608-5E9C5911-64BF-421E-8048-233498588B73Q33648694-9E0EBAAB-F4FB-4CF8-8422-35231109E884Q33731804-F94C4D9D-5296-40CC-A9DF-4038371C419DQ33985586-25833A81-1365-48BA-9EF3-8D4E89E94223Q34016833-E35715E2-C67D-4A66-8781-DB6EE71BA019Q34251380-19AD6BAA-6191-4239-B0B8-861F820218E4Q34413441-03D85594-C571-4B0E-95DD-2139E74B70C1Q34475686-8528F430-C0F7-42A9-84C5-F8931B36499EQ35078297-02921486-DBF0-4951-B4AA-8A1E3EB2EF67Q35177880-23060D20-1ECA-432F-8B2A-2CB93CC364C4Q35585943-89A22061-0517-48DB-B30E-9B9B18B3A4E7Q35890732-12B1F729-3844-4A76-B865-0D40E06CD125Q36261529-D43E5CB8-74F2-49E2-A7C0-1793450C878AQ36463854-60A7107E-E7DD-49A7-9270-5684C494F577Q36563705-25FB5900-0E19-4C7B-930C-2062E054E90CQ36675320-619F927C-3CE9-451D-93BE-E073BE349658Q36926941-7E947246-3795-4AEA-9D1F-24EBF71C7662Q36968401-F6F20B2D-4AF1-4554-B26C-8B6B4D897A46Q36974863-E8102B7C-1486-4E69-8E41-92AB1C8C0000Q37075412-122841D3-9385-48FA-9865-DC5681056C68Q37094281-8F8CCAC3-1DC4-4544-836C-584A81778E47Q37115232-AC2C3A67-C9D1-40E6-B486-A5CC08E1E85AQ37360360-A80D02B0-3EDC-4B55-A70F-49A83DE5F9FAQ37688202-C0C06A84-8F7F-400B-9B3E-C684617E8161Q37708005-FCBAEE16-51FF-4B44-94C9-2D227126AFBCQ38183889-24295A62-43B4-4AC7-88E4-D90FAB988DA0Q38357424-A05D5EDC-65F2-4BBD-85E6-CFC97C4B01D4Q38448721-5ACDC00E-CD42-4C85-9B22-8E370EBCCC23Q38528448-DE0F950A-FEEE-48BA-BE65-A69B121C8C6DQ38638847-529C1552-D2A7-43EB-81B3-1DFE345D16A5Q38995724-DF07AD43-3046-44AA-A196-A424F8BC9AA3
P2860
Aspirin as adjuvant therapy for colorectal cancer--reinterpreting paradigms.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Aspirin as adjuvant therapy for colorectal cancer--reinterpreting paradigms.
@en
type
label
Aspirin as adjuvant therapy for colorectal cancer--reinterpreting paradigms.
@en
prefLabel
Aspirin as adjuvant therapy for colorectal cancer--reinterpreting paradigms.
@en
P2093
P1476
Aspirin as adjuvant therapy for colorectal cancer--reinterpreting paradigms.
@en
P2093
Han Chong Toh
Raghib Ali
Whay Kuang Chia
P2888
P304
P356
10.1038/NRCLINONC.2012.137
P407
P577
2012-08-21T00:00:00Z
P6179
1002317576